Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis

Pharmacogenetics

Volumn 7, Issue 3, 1997, Pages 181-186

  Belloc, Claire ^a   Gauffre, Aline ^a   André, Chantal ^b   Beaune, Philippe H ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Autoimmune hepatitis; Dihydralazine; Epitope mapping; Human CYP1A2

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450 ISOENZYME; DIHYDRALAZINE;

ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG METABOLISM; EPITOPE MAPPING; HUMAN; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CYTOCHROME P-450 CYP1A2; DIHYDRALAZINE; DNA, COMPLEMENTARY; EPITOPE MAPPING; HEPATITIS, TOXIC; HUMANS; MICROSOMES, LIVER;

EID: 0030822761     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199706000-00002     Document Type: Article

References (30)

1. Beaune PH, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux J-P, Homberg JC. Human anti-endoplasmic reticulum autoantibodies appearing in a drug induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987: 84, 551-555.
2. Belloc C, Baird S, Cosme J, Lecoeur S, Gautier J-C, Challine D, De Waziers I, Flinois J-P, Beaune PH. Human cytochromes P450 expressed in Escherichia coli: Production of specific antibodies. Toxicology 1996: 106, 207-219.
3. Birk HW, Koepsell H. Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of nonspecific antibody binding. Anal Biochem 1987: 164, 12-22.
4. Blundell TL, Sibanda BL, Sternberg MJE, Thornton JM. Knowledge-based prediction of protein structures and the design of molecules. Nature 1987: 326, 347-352.
5. Boccacio F, Attali P, Nataf J, Ink O, Fabre M, Pelletier G. Hépatite aiguë due à la dihydralazine. Gastroenterol Clin Biol 1987: 11, 614.
6. Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Gueugerich FP, Beaune PH. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450 1A2: a specific marker of dihydralazine-induced hepatitis. J Clin Invest 1990: 85, 1967-1973.
7. Bourdi M, Gautier J-C, Mircheva J, Larrey D, Guillouzo A, André C, Belloc C, Beaune PH. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. Mol Pharmacol 1992: 42, 280-285.
8. Bourdi M, Tinel M, Beaune PH and Pessayre D. Interactions of dihydralazine with cytochromes P4501A: A possible explanation for the appearance of anti-cytochrome P4501A2 antoantibodies. Mol Pharmacol 1994: 45, 1287-1295.
9. DuclosVallée JC, Hajoui O, Yamamoto AM, Jacqzaigrain E and Alvarez F. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Gastroenterol 1995: 108, 470-476.
10. Finke R, Seto P, Rapoport B. Evidence for the highly conformational nature of the epitope(s) on human thyroid peroxidase that are recognized by sera from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990: 71, 53-59.
11. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 1995: 2, 41-62.
12. Korsekwa KR, Jones JP. Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics 1993: 3, 1-18.
13. Laemmli UK. Cleavage of structural properties during the assembly of the head of bacteriophage T4. Nature 1970: 227, 680-685.
14. Lecoeur S, Bonierbale E, Challine D, Gautier JC, Valadon P, Dansette PM, Catinot R, Ballet F, Mansuy D, Beaune PH. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs. Chem Res Toxicol 1994: 7, 434-442.
15. Lecoeur S, André C, Beaune P. Tienilic acid-induced autoimmune hepatitis: anti-LKM2 autoantibodies recognize a three-site conformational epitope on CYP2C9. Mol Pharmacol 1990: 50, 326-333.
16. Leeder JS, Gaedigk A, Lu X. Epitope mapping studies of h uman anti-CYP3A antibodies in a patient with anticonvulsivant hypersensitivity. Sixth North American ISSX Meeting 1994: 6, 53.
17. Leeder JS, Gaedigk A, Lu X, Cook VA. Epitope mapping studies with human anti-cytochrome P450 3A antibodies. Mol Pharmacol 1996: 49, 234-243.
18. Leung PSC, Chuang DT, Wynn RM, Cha S, Danner DJ, Ansari A, Coppel RL, Gerscwin RE. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995: 22, 505-513.
19. Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich FP, Pessayre D. Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies. Gastroenterol 1993: 104, 203-216.
20. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450 2D6, a cytochrome P450 monooxygenase. J Clin Invest 1991: 88, 1370-1378.
21. Nataf J, Bernuau J, Larrey D, Guillin MC, Rueff B, Benhamou J-P. A new anti-liver microsome antibody: a specific marker of dihydralazine-induced hepatitis. Gastroenterol 1986: 90, 1751.
22. Pariente EA, Pessayre D, Bernueau J, Degott C, Benhamou JP. Dihydralazine hepatitis: report of a case and review of the literature. Digestion 1983: 27, 47-52.
23. Richter W, Shi Y, Baekkeskov S. Antoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993: 90, 2832-2836.
24. Sanger F, Nicklens S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci 1977: 74, 5463-5467.
25. Satoh H, Martin BM, Schulick AH, Christ DD, Kenna JG, Pohl LR. Human anti endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci 1989: 86, 322-326.
26. Song YH, Connor EL, Muir A, She JX, Zorovich B, Derovanesian D, Maclaren N. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J Clin Endocrinol Metab 1994: 78, 1108-1112.
27. Stott DI. Immunoblotting and dot blotting. J Immunol Methods 1989: 119, 153-187.
28. Towbin HT, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979: 76, 4350-4354.
29. Wedlock N, Asawa T, Baumann-Antezak A, Smith BR, Furmaniak J. Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS Lett 1993: 332, 123-126.
30. Yamamoto AM, Cresteil D, Boniface O, Clerc FF, Alvarez F. Identification and analysis of cytochrome-P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol 1993: 23, 1105-1111.